TL-925
Phase 2- Indications
- Conjunctivitis
Company intelligence / Profile preview
Integra LifeSciences commercializes FDA-approved medical devices including the first reproducible artificial skin used in severe burns, dural grafts for neurosurgery/spine procedures, nerve/tendon/orthobiologic implants, advanced wound care products, and surgical instruments. Its products are widely adopted in hospitals worldwide with ongoing innovation in regenerative medicine.
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Integra LifeSciences.